iPS cells offer scientists a fresh approach to diabetes cure

By taking adult stem cells from patients with Type 1 diabetes and reprogramming them into induced pluripotent stem (iPS) cells, scientists have been able to watch as the disease develops. That front row seat offers a unique perspective that should help researchers advance a cure for the disease.

"What you get is the ability to watch, for the first time, Type 1 diabetes develop," says senior author Douglas Melton, the co-director of the Harvard Stem Cell Institute. "Until you watch a disease develop, you will not understand the mechanism, and you therefore cannot devise any kind of sensible treatment or cure."

The reprogrammed cells can be transformed into insulin-producing pancreatic beta cells, which are destroyed by the disease. "It's completely mind boggling that you can actually study human disease in a dish," Jeanne Loring, a Scripps researcher, tells Technology Review.

- read the story from Technology Review

Suggested Articles

Antibiotics dubbed odilorhabdins (ODLs), inspired by soil-dwelling nematodes, hold promise for treating antibiotic-resistant infections.

A PureTech startup is developing an immune-responsive hydrogel that releases a corticosteroid into arthritic joints based on their level of inflammation.

A trial of a retinal implant built from embryonic stem cells produced encouraging results in patients with dry age-related macular degeneration.